DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension

DAMP 信号介导 HIMF 诱导的肺动脉高压

基本信息

  • 批准号:
    10206240
  • 负责人:
  • 金额:
    $ 45.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

SUMMARY Hypoxia-induced mitogenic factor (HIMF; also known as FIZZ1 or resistin-like molecule-) is critical to pulmonary hypertension (PH) development in rodent models, and our work suggests that HIMF may trigger a positive feedback loop to amplify the vascular inflammation required for remodeling. We have implicated the human homolog of HIMF, human resistin (hresistin) in human idiopathic and scleroderma related PH. Several downstream vascular and immune processes critical to rodent and human PH are activated by HIMF and hresistin but the manner in which HIMF/hresistin initiates these responses in a pathologic manner remains unknown. Damage-associated molecular pattern molecules (DAMPs), including high mobility group box (HMGB)1 and S100 calcium binding proteins, act as endogenous danger signals to regulate the subsequent inflammatory response through an autocrine and paracrine manner via activation of the receptor for advanced glycation end-products (RAGE). We now show HIMF and hresistin-induced HMGB1 and S100A11 activation in human vascular and immune cells related to PH and in PH animal models. However the mechanism of HIMF/hresistin regulation of this response and the function of the HIMF/DAMP/RAGE signaling axis during PH development remain unclear. In preliminary studies, we found that HIMF signaling activates HMGB1/RAGE axis in vivo and in vitro in association with suppressed sirtuin (Sirt)1, enhanced autophagy, attenuated expression of forkhead box O (FoxO)1 and bone morphogenetic protein receptor (BMPR)2, and hyper- proliferation of pulmonary artery smooth muscle cells (PASMC). In addition, in our preliminary studies another DAMP, the S100A11, also has been found to increase in peripheral blood mononuclear cells of PH patients. In this proposal, we hypothesize that HIMF/hresistin activated DAMP signaling mediates the cross- talk between vascular cells and immune cells, initiates an autophagic response, and downregulates FoxO1 and BMPR2, thereby contributing to PH pathophysiology. We will investigate the role of DAMPs in HIMF-induced inflammatory response and subsequent vascular remodeling by illustrating their cellular and molecular signaling processes initiated by HIMF and elucidating the underlying mechanism. The three related specific aims are directed at understanding: (1) the roles of HIMF in mediating the intracellular and extracellular activity and the epigenetic modification of DAMP molecules; (2) the downstream events of the HIMF/DAMP signaling axis, including autophagy/apoptosis regulation, BMPR2 and FoxO1 downregulation and their possible interaction; and (3) the expression/production of DAMPs and their downstream mediators in PH development, as well as the correlation of these molecules in existing clinical PH patient specimens. The goal of this proposal is to further clarify the relation between the immunomodulatory properties of HIMF and the etiology of PH, and thereby to explore a novel therapeutic approach for PH and other vascular inflammation-related diseases.
摘要 低氧诱导的有丝分裂因子(HIMF;也称为FIZZ1或抵抗素样分子-)在 在啮齿动物模型中发生肺动脉高压,我们的工作表明,HIMF可能触发了 正反馈环,放大重塑所需的血管炎症。我们已经牵连到 人类特发性和硬皮病相关的PH中的人类HIMF、人类抵抗素(HResistn)同源物。几个 Himf和Himf激活对啮齿动物和人类PH至关重要的下游血管和免疫过程 但HIMF/HResitn以病理性方式启动这些反应的方式仍然存在 未知。损伤相关分子图案分子(DAMP),包括高迁移率基团框 (HMGB)1和S100钙结合蛋白作为内源性危险信号调节随后的 通过激活晚期受体的自分泌和旁分泌方式的炎症反应 糖基化终产物(RAGE)。我们现在展示了Himf和hResistn诱导的HMGB1和S100A11在 人类血管和免疫细胞与肺高压相关,以及在肺高压动物模型中。然而,它的作用机制 Himf/hResistn对这一反应的调节以及Himf/DAMP/RAGE信号轴在PH中的作用 事态发展仍不明朗。在初步研究中,我们发现Himf信号激活了HMGB1/RAGE AXIS在体内和体外与抑制的sirtuin(Sirt)1相关,增强的自噬,减弱 叉头盒O(FoxO)1和骨形态发生蛋白受体(BMPR)2的表达 PASMC的增殖情况。此外,在我们的初步研究中,另一项 DAMP,S100A11,也被发现在PH患者的外周血单核细胞中增加。 在这一建议中,我们假设Himf/hResitin激活的DAMP信号介导了交叉反应。 血管细胞和免疫细胞之间的对话,启动自噬反应,并下调 Foxo1和BMPR2,从而参与了PH的病理生理过程。我们将研究阻尼器的作用 在HIMF诱导的炎症反应和随后的血管重塑中 由HIF启动的细胞和分子信号传递过程及其潜在的 机制。三个相关的具体目的是为了理解:(1)他在 介导细胞内外活性和DAMP分子的表观遗传修饰;(2) HIMF/DAMP信号轴的下游事件,包括自噬/凋亡调节,BMPR2和 Foxo1下调及其可能的相互作用;以及(3)DAMP及其受体的表达/产生 肺高压发生中的下游介质以及这些分子在现有的临床肺高压中的相关性 病人样本。这项建议的目的是进一步澄清免疫调节与 HIF的特性和PH的病因,从而探索一种新的治疗PH和 其他与血管炎症相关的疾病。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Resistin-Like Molecule α Dysregulates Cardiac Bioenergetics in Neonatal Rat Cardiomyocytes.
  • DOI:
    10.3389/fcvm.2021.574708
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Tao B;Kumar S;Gomez-Arroyo J;Fan C;Zhang A;Skinner J;Hunter E;Yamaji-Kegan K;Samad I;Hillel AT;Lin Q;Zhai W;Gao WD;Johns RA
  • 通讯作者:
    Johns RA
Human Resistin Induces Cardiac Dysfunction in Pulmonary Hypertension.
  • DOI:
    10.1161/jaha.122.027621
  • 发表时间:
    2023-03-21
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Lin, Qing;Kumar, Santosh;Kariyawasam, Udeshika;Yang, Xiaomei;Yang, Wei;Skinner, John T.;Gao, Wei Dong;Johns, Roger A.
  • 通讯作者:
    Johns, Roger A.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Roger A Johns其他文献

Increased Pulmonary Blood Flow as a Regulator of Pulmonary Vascular Remodeling: Role of eNOS ♦ 105
  • DOI:
    10.1203/00006450-199704001-00126
  • 发表时间:
    1997-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Allen D Everett;Timothy D Le Cras;Chun Xue;Roger A Johns
  • 通讯作者:
    Roger A Johns

Roger A Johns的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Roger A Johns', 18)}}的其他基金

Resistin regulates NLRP3 inflammasome in pulmonary hypertension
抵抗素调节肺动脉高压中的 NLRP3 炎性体
  • 批准号:
    10567914
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension
DAMP 信号介导 HIMF 诱导的肺动脉高压
  • 批准号:
    9976575
  • 财政年份:
    2018
  • 资助金额:
    $ 45.49万
  • 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
  • 批准号:
    10390873
  • 财政年份:
    2014
  • 资助金额:
    $ 45.49万
  • 项目类别:
Targeting resitin and RELM-beta to treat pulmonary hypertension
靶向抵抗素和 RELM-β 治疗肺动脉高压
  • 批准号:
    8757198
  • 财政年份:
    2014
  • 资助金额:
    $ 45.49万
  • 项目类别:
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction
靶向 PDZ 来解决早期麻醉暴露引起的认知功能障碍
  • 批准号:
    9016565
  • 财政年份:
    2014
  • 资助金额:
    $ 45.49万
  • 项目类别:
Targeting resitin and RELM-beta to treat pulmonary hypertension
靶向抵抗素和 RELM-β 治疗肺动脉高压
  • 批准号:
    9335421
  • 财政年份:
    2014
  • 资助金额:
    $ 45.49万
  • 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
  • 批准号:
    10649603
  • 财政年份:
    2014
  • 资助金额:
    $ 45.49万
  • 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
  • 批准号:
    10212402
  • 财政年份:
    2014
  • 资助金额:
    $ 45.49万
  • 项目类别:
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction
靶向 PDZ 来解决早期麻醉暴露引起的认知功能障碍
  • 批准号:
    8673354
  • 财政年份:
    2014
  • 资助金额:
    $ 45.49万
  • 项目类别:
Targeting resitin and RELM-beta to treat pulmonary hypertension
靶向抵抗素和 RELM-β 治疗肺动脉高压
  • 批准号:
    8931049
  • 财政年份:
    2014
  • 资助金额:
    $ 45.49万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 45.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了